![Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41537-022-00320-1/MediaObjects/41537_2022_320_Fig4_HTML.png)
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia
![Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41537-022-00320-1/MediaObjects/41537_2022_320_Fig1_HTML.png)
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia
![Modafinil and the risk of cardiovascular events: Findings from three US claims databases - Kaplan - 2018 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Modafinil and the risk of cardiovascular events: Findings from three US claims databases - Kaplan - 2018 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/31beac85-24ac-4c9c-858a-0fbd2a83d805/pds.v27.11.cover.jpg?trick=1669962403400)
Modafinil and the risk of cardiovascular events: Findings from three US claims databases - Kaplan - 2018 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
![Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41537-022-00320-1/MediaObjects/41537_2022_320_Fig5_HTML.png)
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia | Schizophrenia
![Modafinil and the risk of cardiovascular events: Findings from three US claims databases - Kaplan - 2018 - Pharmacoepidemiology and Drug Safety - Wiley Online Library Modafinil and the risk of cardiovascular events: Findings from three US claims databases - Kaplan - 2018 - Pharmacoepidemiology and Drug Safety - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/641d6a57-51e4-4135-be6b-0fa31d8e2606/pds4642-fig-0001-m.jpg)